Why the study?
Does the Framingham Risk Score underestimate cardiovascular risk in young patients with acute myocardial infarction?
Does the Framingham Risk Score underestimate cardiovascular risk in young patients with acute myocardial infarction?
The Framingham Risk Score appears to underestimate global cardiovascular risk in young patients with premature myocardial infarction, despite a high prevalence of metabolic syndrome.
Answers are grounded in this paper and cite their sources.
Framingham Risk Score may underestimate CV risk in young AMI patients with metabolic syndrome; hypothesis-generating for improved stratification.
To assess the prevalence of metabolic syndrome (MS) and estimates of global risk by Framingham Risk Score in young subjects with acute myocardial infarction (MI), we assessed metabolic parameters and global risk assessment in 165 consecutive subjects who presented with myocardial infarction prior to 45 years of age. Nearly 80% of subjects were overweight or obese and at least one cardiovascular risk factor was present in 96% of patients. MS with or without overt diabetes was present in nearly two thirds of subjects. Excluding subjects with diabetes, the mean 10-year Framingham Risk Score estimate in the total cohort was 9.3%, with only 17.1% of subjects having a 10-year risk greater than 20%. Only 28% of subjects with MS had a Framingham Risk Score greater than 20%. Although MS is present in nearly two thirds of young patients with premature myocardial infarction, the Framingham Risk Score appears to underestimate global cardiovascular risk in this population.
No takes yet. Share an insight, caveat, or question.
Zarich et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: